Nanoparticle based treatment for cardiovascular diseases Article

Gupta, P, Garcia, E, Sarkar, A et al. (2019). Nanoparticle based treatment for cardiovascular diseases . 19(1), 33-44. 10.2174/1871529X18666180508113253

cited authors

  • Gupta, P; Garcia, E; Sarkar, A; Kapoor, S; Rafiq, K; Chand, HS; Jayant, RD



  • Nanotechnology has gained increased attention for delivering therapeutic agents effectively to the cardiovascular system. Heart targeted nanocarrier based drug delivery is a new, effective and efficacious approach for treating various cardiac related disorders such as atherosclerosis, hypertension, and myocardial infarction. Nanocarrier based drug delivery system circumvents the problems associated with conventional drug delivery systems, including their nonspecificity, severe side effects and damage to the normal cells. Modification of physicochemical properties of nanocarriers such as size, shape and surface modifications can immensely alter its invivo pharmacokinetic and pharmacodynamic data and will provide better treatment strategy. Several nanocarriers such as lipid, phospholipid nanoparticles have been developed for delivering drugs to the target sites within the heart. This review summarizes and increases the understanding of the advanced nanosized drug delivery systems for treating cardiovascular disorders with the promising use of nanotechnology.

publication date

  • January 1, 2019

Digital Object Identifier (DOI)

start page

  • 33

end page

  • 44


  • 19


  • 1